You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

well-differentiated and bronchoalveolar lung cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Neuroendocrine Tumors, NET, Pancreatic Neuroendocrine Tumor Trial in Newport Beach, Denver, Dallas (nab-sirolimus)

Not yet recruiting
  • Neuroendocrine Tumors
  • +4 more
  • Newport Beach, California
  • +2 more
Aug 16, 2023

Pattern of Isolated Fungi From Bronchoalveolar Lavage Among Lung

Completed
  • Lung Cancer
    • Mansoura, Egypt
      Faculty of Medicine
    Oct 10, 2022

    Neuroendocrine Tumors, Neuroendocrine Carcinoma, Neuroendocrine Cancer Trial in Tampa (Pembrolizumab, Lenvatinib)

    Active, not recruiting
    • Neuroendocrine Tumors
    • +2 more
    • Tampa, Florida
      H. Lee Moffitt Cancer Center and Research Institute
    Jan 24, 2023

    Neuroendocrine Tumors, Progesterone Receptor Positive Tumor, Estrogen Receptor Positive Tumor Trial in São Paulo (Tamoxifen)

    Active, not recruiting
    • Neuroendocrine Tumors
    • +2 more
    • Tampa, Florida
    • +1 more
    Jan 13, 2023

    Detecting Epigenetic Imprinting Alterations in Bronchoalveolar

    Recruiting
    • Lung Cancer
    • Quantitative Chromogenic Imprinted Gene in situ Hybridization (QCIGISH)
    • Nanjing, Jiangsu, China
    • +2 more
    Jan 29, 2023

    Digestive System Neuroendocrine Tumor G1, Digestive System Neuroendocrine Tumor G2, Metastatic Digestive System Neuroendocrine

    Not yet recruiting
    • Digestive System Neuroendocrine Tumor G1
    • +5 more
    • Tumor Debulking
    • +5 more
    • Nashville, Tennessee
      Vanderbilt University/Ingram Cancer Center
    Aug 23, 2023

    Neuroendocrine Tumors Trial in New York (177Lu-DOTA-EB-TATE, Amino Acid Solution)

    Recruiting
    • Neuroendocrine Tumors
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Jul 22, 2022

    Neuroendocrine Tumors Trial in São Paulo (MIBG-I131)

    Withdrawn
    • Neuroendocrine Tumors
    • MIBG-I131
    • São Paulo, SP, Brazil
      AC Camargo Cancer Center
    May 13, 2022

    NSCLC Trial in Liège (induced sputum, lung biopsy, bronchoalveolar lavage)

    Recruiting
    • Non-small Cell Lung Cancer
    • induced sputum
    • +3 more
    • Liège, Belgium
      CHU de Liège
    Nov 7, 2022

    Nashville Early Diagnosis Lung Cancer Project

    Active, not recruiting
    • Lung Cancer
    • Sputum sample
    • +9 more
    • Nashville, Tennessee
    • +1 more
    Oct 27, 2022

    Cigarette Smoker, Current Every Day Smoker Trial in Columbus (procedure, drug, other)

    Recruiting
    • Cigarette Smoker
    • Current Every Day Smoker
    • Bronchoscopy with Bronchoalveolar Lavage
    • +5 more
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Jan 5, 2023

    Thyroglobulin and Galectin-3 for Prognosis and Follow-up in

    Recruiting
    • Thyroid Cancer
    • +2 more
      • Taipei, Taiwan
        Chih-Yuan Wang, M.D
      Oct 16, 2022

      GEP-NET, Gastroenteropancreatic Neuroendocrine Tumor, Gastroenteropancreatic Neuroendocrine Tumor Disease Trial in United States

      Recruiting
      • GEP-NET
      • +6 more
      • Duarte, California
      • +3 more
      Jul 28, 2022

      Small Cell Lung Carcinoma (SCLC) Trial (BI 764532, Topotecan)

      Not yet recruiting
      • Small Cell Lung Carcinoma (SCLC)
      • (no location specified)
      Aug 7, 2023

      Lung Cancer Trial in Le Plessis Robinson (treatment with immunotherapy and diffuse infiltrative lung disease, Patients requiring

      Recruiting
      • Lung Cancer
      • treatment with immunotherapy and diffuse infiltrative lung disease
      • Patients requiring carcinologic lobectomy
      • Le Plessis Robinson, France
        Centre Chirurgical Marie Lannelongue
      Nov 2, 2021

      Neuroendocrine Tumors Trial in Lexington (Telotristat (Low-Dose), Telotristat (High-Dose))

      Recruiting
      • Neuroendocrine Tumors
      • Telotristat (Low-Dose)
      • Telotristat (High-Dose)
      • Lexington, Kentucky
        Markey Cancer Center
      Nov 10, 2022

      Small Cell Lung Carcinoma (SCLC) Trial (BI 764532, Carboplatin, Etoposide)

      Not yet recruiting
      • Small Cell Lung Carcinoma (SCLC)
      • BI 764532
      • +5 more
      • (no location specified)
      Oct 17, 2023

      PD1-lymphocytes in Bronchoalveolar Lavage of Lung Cancer

      Recruiting
      • Lung Cancer
      • bronchoalveolar lavage
      • Vienna, Austria
        Medical University of Vienna
      Apr 4, 2021

      Small Cell Lung Carcinoma (SCLC), Neuroendocrine Tumors Trial (BI 764532, Ezabenlimab)

      Not yet recruiting
      • Small Cell Lung Carcinoma (SCLC)
      • Neuroendocrine Neoplasms
      • (no location specified)
      May 25, 2023

      Neuroendocrine Tumors, Liver-Dominant Metastatic Pancreatic Neuroendocrine Tumors Trial in New York (177Lu-DOTATATE)

      Recruiting
      • Neuroendocrine Tumors
      • Liver-Dominant Metastatic Pancreatic Neuroendocrine Tumors
      • New York, New York
        Memorial Sloan Kettering Cancer Center
      Jan 19, 2023

      Thyroid Trial in Philadelphia (Metformin Hydrochloride, Radioactive Iodine, Placebo)

      Active, not recruiting
      • Thyroid
      • Metformin Hydrochloride
      • +2 more
      • Philadelphia, Pennsylvania
        Sidney Kimmel Cancer Center at Thomas Jefferson University
      Aug 31, 2021

      Metastatic Lung Small Cell Carcinoma, Metastatic Malignant Solid Tumor, Metastatic Neuroendocrine Carcinoma Trial in United

      Recruiting
      • Metastatic Lung Small Cell Carcinoma
      • +16 more
      • Phoenix, Arizona
      • +10 more
      Mar 25, 2022

      Neuroendocrine Tumors Trial in Worldwide (177Lu-Edotreotide (Peptide Receptor Radionuclide Therapy) PRRT, CAPTEM (Capecitabine

      Recruiting
      • Neuroendocrine Tumors
      • 177Lu-Edotreotide (Peptide Receptor Radionuclide Therapy) PRRT
      • +4 more
      • Palo Alto, California
      • +30 more
      Dec 14, 2022

      Neuroendocrine Tumors Trial in Toronto (F18-FDG)

      Recruiting
      • Neuroendocrine Tumors
      • Toronto, Ontario, Canada
        Princess Margaret Cancer Centre
      May 20, 2022

      Pancreatic Cancer Dietary Assessment Study

      Completed
      • Pancreatic Neoplasm
      • +3 more
      • Pancreo-KIT breath test
      • Manchester, United Kingdom
        The Christie NHS Foundation Trust
      Feb 1, 2022